Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection ...

09/17/19

Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding  Yahoo Finance

Sienna Biopharmaceuticals, Inc. (SNNA), a clinical-stage biopharmaceutical company, today announced that it has elected to file a voluntary petition to allow ...

[more]